SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Align Research update note

12 Oct 2017 07:00

RNS Number : 3758T
Obtala Limited
11 October 2017
 

Obtala Limited - Conviction Buy. Target price 38.18p

Step change in revenues evident following interims & Q3 update

Obtala Limited is an Africa focussed forestry and agriculture company with a goal of becoming one of Sub-Saharan Africa's largest sustainable food and timber producers.

Interims show period of investment & Woodbois value made apparent

Obtala posted an operating loss of $3.8 million for the six months to 30th June 2017 but a statutory profit of $22.7 million following a gain on the acquisition of Woodbois. An independent valuation of the forestry and timber trading firm added $53.3 million to Obtala's biological asset value. This compares to a revised purchase price for Woodbois of $12.2 million.

Q3 update shows further progress and additional funds raised

The three months to September 2017 saw the end of the forestry close cutting season in Mozambique, the first significant harvests from the agriculture division and the first contribution from the Woodbois acquisition. An additional $2 million has also been raised to support growth via a further preference share in the forestry subsidiary Argento Limited.

Corporate structure re-organised with new Boards appointed

Obtala will now report to the markets via the three divisions of Timber Trading, Timber Production (together the Forestry division) and Agriculture Production. To support this, new boards have been appointed to the Argento (forestry) and Montara (agriculture) subsidiaries.

DCF derived target price of 38.18p suggests 117% upside

Obtala is now seeing a step change in revenue and profit growth across the three divisions of the business. Nevertheless, the shares trade at a substantial discount to net assets, with the market cap c.90% covered by Obtala's stake in Argento alone. Our DCF analysis suggests a target price of 38.18p, therefore we retain our stance of Conviction Buy.

To download the full note visit http://www.alignresearch.co.uk/cpt-company/obtala/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMBBPTMBBBBBR
Date   Source Headline
24th Aug 20207:00 amRNSSPOTT Transparency Assessment & Notice of Results
11th Aug 20203:15 pmRNSHolding(s) in Company
10th Aug 20201:30 pmRNSHolding(s) in Company
7th Aug 202012:25 pmRNSHolding(s) in Company
5th Aug 202011:15 amRNSResults of General Meeting
29th Jul 20207:00 amRNSNotification of Holdings in Company
27th Jul 20207:00 amRNSFurther Conversion of the Convertible Bonds
16th Jul 20203:15 pmRNSPosting of documents in relation to Placing
15th Jul 20207:00 amRNSResult of Conditional Fundraise
14th Jul 20204:46 pmRNSPrimaryBid.com Offer
14th Jul 20204:45 pmRNSProposed Placing and Debt Restructuring
30th Jun 202011:20 amRNSResults of Annual General Meeting
19th Jun 20207:00 amRNSCompany Update
11th Jun 20207:01 amRNSOperational Update
11th Jun 20207:00 amRNSAppointment of Nomad and Broker
3rd Jun 20207:00 amRNSNotice of AGM
7th May 20207:00 amRNSCorporate Presentation
30th Apr 20207:00 amRNSFinal Results
16th Apr 20207:00 amRNSQuarterly Update
7th Apr 20203:40 pmRNSHolding(s) in Company
27th Mar 20207:00 amRNSCOVID-19 update
19th Mar 20207:00 amRNSMozambique Agreement & Operations recommencement
3rd Mar 20207:00 amRNSCorporate Presentation
16th Jan 20207:30 amRNSFurther re 2020 cash flow enhancement
16th Jan 20207:00 amRNS2020 cash flow enhancement and additional funds
7th Jan 20207:00 amRNSQuarterly Update
13th Dec 20198:12 amRNSHolding(s) in Company
29th Nov 20197:00 amRNSTimber Offtake Agreement MOU
21st Oct 20193:31 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSPreference Share Restructure into 4% Convertible
10th Oct 20197:00 amRNSQuarterly Update
26th Sep 201910:56 amRNSHolding(s) in Company - Amendment
26th Sep 201910:55 amRNSHolding(s) in Company
26th Sep 20198:16 amRNSHolding(s) in Company
26th Sep 20198:15 amRNSHolding(s) in Company
24th Sep 201910:31 amRNSHolding(s) in Company
20th Sep 20193:38 pmRNSPreference Share Restructure
11th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
15th Aug 20197:00 amRNSSPOTT Transparency Assessment
25th Jul 20197:00 amRNSWarrant Amendment
11th Jul 201912:20 pmRNSQuarterly Update
19th Jun 201911:58 amRNSResult of AGM
23rd May 20197:00 amRNSNotice of AGM
21st May 20197:00 amRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSDirector/PDMR Shareholding
17th May 201910:36 amRNSDirector/PDMR Shareholding
16th May 20193:18 pmRNSDirector/PDMR Shareholding
13th May 20197:01 amRNSAppointment of Non-Executive Director
13th May 20197:00 amRNSFinal Results FY18
2nd Apr 20197:00 amRNSQuarterly Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.